Results 11 to 20 of about 2,931 (217)

Is a Malleable Active Site Loop the Key to High Substrate Promiscuity? Hybrid, Biocatalytic Route to Structurally Diverse Taxoid Side Chains with Remarkable Dual Stereocontrol. [PDF]

open access: yesAngew Chem Int Ed Engl
These studies reveal the first structure of Clostridium acetobutylicum alcohol dehydrogenase (CaADH), a protein exhibiting remarkable substrate promiscuity and stereochemical fidelity.
Kudalkar GP   +15 more
europepmc   +6 more sources

Fluorescent taxoid probes for microtubule research.

open access: yesMethods in Cell Biology, 2010
The use of the antitumor drug taxol as an experimental microtubule-stabilizing agent is widespread. Fluorescent taxol conjugates, although less employed, are very useful tools for several purposes in microtubule research. These include easily visualizing microtubule cytoskeletons in a variety of cells as well as in vitro assembled microtubules ...
I. Barasoaín, J. F. Díaz, J. Andreu
semanticscholar   +5 more sources

Construction of Enantiopure Taxoid and Natural Product-like Scaffolds Using a C-C Bond Cleavage/Arylation Reaction.

open access: yesOrganic Letters, 2015
An approach to construct enantiopure complex natural product-like frameworks, including the first reported synthesis of a C17 oxygenated taxoid scaffold, is presented.
M. Weber   +3 more
semanticscholar   +3 more sources

Identification of potential genes that contributed to the variation in the taxoid contents between two Taxus species (Taxus media and Taxus mairei)

open access: yesTree Physiology, 2017
Taxol is currently a valuable anticancer drug; however, the accumulated mixture of taxoids can vary greatly among Taxus species. So far, there is very little genomic information for the genus Taxus, except for Taxus baccata.
Chunna Yu   +10 more
semanticscholar   +2 more sources

Prostate cancer stem cell-targeted efficacy of a new-generation taxoid, SBT-1214 and novel polyenolic zinc-binding curcuminoid, CMC2.24. [PDF]

open access: yesPLoS ONE, 2013
Prostate cancer is the second leading cause of cancer death among men. Multiple evidence suggests that a population of tumor-initiating, or cancer stem cells (CSCs) is responsible for cancer development and exceptional drug resistance, representing a ...
Galina I Botchkina   +10 more
doaj   +2 more sources

Analysis of MS/MS Fragmentation of Taxoids [PDF]

open access: yesNatural Product Communications, 2010
The fragmentation pathways of seven types of taxoids were investigated by using a LC-MS/MS method, namely: (1) neutral taxoids with a C-4(20) double bond; (2) taxoids with a C-4(20) double bond and oxygenation at C-14; (3) 5-cinnamoyl taxoids with a C-4 ...
Kouhei Morikawa   +6 more
doaj   +3 more sources

New-generation taxoid SB-T-1214 inhibits stem cell-related gene expression in 3D cancer spheroids induced by purified colon tumor-initiating cells

open access: yesMolecular Cancer, 2010
Background Growing evidence suggests that the majority of tumors are organized hierarchically, comprising a population of tumor-initiating, or cancer stem cells (CSCs) responsible for tumor development, maintenance and resistance to drugs.
Rowehl Rebecca A   +11 more
doaj   +2 more sources

Antisense-induced suppression of taxoid 14 β- hydroxylase gene expression in transgenic Taxus × media cells [PDF]

open access: yes, 2011
The enzyme taxoid 14β-hydroxylase (14OH) directs a side-route of taxol pathway to 14β-hydroxy taxoids. Suppression of this side-route could increase the production of taxol.
Feng-Lan Li   +5 more
semanticscholar   +2 more sources

Recent advances in the strategic incorporation of fluorine into new-generation taxoid anticancer agents. [PDF]

open access: yesJ Fluor Chem, 2023
This account describes our recent progress on the strategic incorporation of fluorine and organofluorine moieties into new-generation taxoid anticancer agents for medicinal chemistry and chemical biology studies. In the case study 1, novel 3rd-generation
Jayanetti K   +4 more
europepmc   +2 more sources

Paclitaxel biological synthesis promotes the innovation of anti-cancer drugs. [PDF]

open access: yesClin Transl Med
Clinical and Translational Medicine, Volume 15, Issue 2, February 2025.
Zhang X, Liu G, Yan J.
europepmc   +2 more sources

Home - About - Disclaimer - Privacy